The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,172,048 in first-year total cost, median $586,024.
Most frequent study sections
- Special Emphasis Panel[ZTR1 DPI-5 (01)]2
Most frequent institutions
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
- UNIVERSITY OF WASHINGTON1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Drug Screening with a Biofrabricated 3-D Immunocompetent Skin Model for Drug Discovery in Psoriatic Disease1U18TR003211-01 | CHRISTIANO, ANGELA M | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $646,512 | ZTR1 |
| 2020 | Biofabricated 3-D skin model for antiviral drug discovery against human HSV infection1U18TR003208-01 | ZHU, JIA | UNIVERSITY OF WASHINGTON, WA | $525,536 | ZTR1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.